Most Recent
The receivers of Sydney fraudster Melissa Caddick's estate have reached an agreement with her husband on a small pool of remaining assets in dispute that will see half of her teenaged son's sneaker collection sold to repay defrauded investors.
ANZ is facing proceedings by a shareholder who wants the bank to turn over documents related to its risk management systems in response to concerns it is increasing loans to fossil fuel companies and failing to properly address climate change risks.
The government of India has flagged a possible special leave application if it loses its appeal of a decision finding it can't avoid a $111.3 million arbitral award in a dispute with three Mauritian companies that invested in Indian satellites because it waived its foreign state immunity.
Superannuation fund trustee H.E.S.T Australia has paid a $48,600 fine after being slapped with three infringement notices by the corporate regulator over alleged misleading statements in Facebook and Instagram ads.
The federal government has announced a review into a nationwide Optus outage that left millions of customers without coverage and affected triple zero calls.
Glencore-owned Viterra has failed in its bid for High Court leave to challenge a ruling in a 10-year battle with Cargill over the 2013 sale of malt producer Joe White, leaving the grain producer to fork over damages of almost $300 million.
South Korean biosimilars company Samsung Bioepis has sued to invalidate two patents held by a German competitor for a pre-filled syringe to treat age-related eye diseases, as generic drug makers race for a piece of the lucrative eye drug market.
The Indian government has lodged an appeal after a judge found it can't avoid a $111.3 million arbitral award in a dispute with three Mauritian companies that invested in Indian satellites.
The ACCC has raised concerns over Qantas’ alleged failure to respond to claims in a blockbuster case against the airline over the sale of tickets on cancelled flights.
An investigation is underway against US medical device maker Exactech on behalf of patients who allegedly received faulty hip, knee or ankle implants.